Dr. Jack West reviews new data on patterns of acquired resistance after a response to immune checkpoint inhibitors for advanced…
Browsing: Acute Lymphoblastic Leukemia
To improve the efficacy of immunotherapy in patients with glioblastoma (GBM), the mechanisms behind the phenomenon of why bone marrow…
Glioblastoma (GBM) is a common and aggressive cancer that starts within the brain. So far, patients with GBM who undergo…
Genetic testing is not always routinely available to breast and/or ovarian cancer patients, or those at high-risk of developing these…
Due to advancements in genetic testing, women who have breast and/or ovarian cancer, or who are at high-risk of developing…
The 2018 Annual Hematology/Oncology Pharmacy Association (HOPA) Conference, held in Denver, CO, saw many thought-provoking sessions and exciting updates. Here,…
Here, Kirollos Hanna, PharmD, BCOP, BCPS, of the University of Minnesota Medical Center, Minneapolis, MN, gives an insight into his…
Speaking from the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Kirollos Hanna, PharmD, BCOP, BCPS, of…
Following the success of a collaborative educational training event in India run by the European Blood and Marrow Transplantation Nurses…
The future is looking bright for bladder cancer, with many clinical studies of new therapeutic options underway. Speaking from the…
The European Blood and Marrow Transplantation Nurses Group (EBMT NG) started a collaborative educational training project in India, which is…
New and exciting developments on urothelial cancer were presented at the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in…
The European Blood and Marrow Transplantation Nurses Group (EBMT NG) ran a successful educational training event in India. Here, Meera…
Following the success of a collaborative educational training event in India run by the European Blood and Marrow Transplantation Nurses…
This activity has been designed to inform oncologists who manage patients with mCRC how to safely and effectively incorporate dose…
Dr. Jack West summarizes the evolving data shaping our understanding of the role of immune checkpoint inhibitors for patients with…
Graft versus host disease (GvHD) remains to be one of the leading causes of morbidity and mortality in patients who…
It is an exciting time in the field of graft versus host disease (GvHD) research, as new drugs for the…
At present, the standard frontline therapy of steroids for graft versus host disease (GvHD) has shown to be ineffective for…
At the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland, we asked a range of experts…
A record number of delegates attended the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland. Although…
Dr. Jack West reviews the preliminary positive result form the IMpower131 trial of chemo +/- atezolizumab immunotherapy and considers what…
Maxine Sun, MD Dana-Farber Cancer Institute, discusses how Statistical Analysis Plans are Useful for Clinician Scientists They can go over…
Walter M. Stadler, MD University of Chicago, discusses Genomic and Expression Profling Soon to be part of treatment decision making…
Maxine Sun, MD Dana-Farber Cancer Institute, discusses Planning and Identification of the Statistical Methodologies Consult biostatistician for opinions on the…
Brian M. Shuch, MD Yale School of Medicine, discusses how S1500’s Completion May Alter Standard of Care for PRCC Compares…
Walter M. Stadler, MD University of Chicago, discusses how they May Select Patients for VEGF or PD-1 Targeted Further investigation…
Maxine Sun, MD Dana-Farber Cancer Institute, discusses The Importance of Statistical Analysis Plans Minimize errors, reduce amount of surprises, &…
Robert Uzzo, MD Fox Chase Cancer Center, discusses the Role of Government in Health Care Political climate raises questions on…
Walter M. Stadler, MD University of Chicago, discusses Biomarker Data From Phase II Trial Preliminary expression profiling at Kidney Cancer…
Brian M. Shuch, MD Yale School of Medicine, discusses the SWOG S1500 – Randomized Phase II Trial Efficacy assessment of…
Tian Zhang, MD Duke University Medical Center, explains the Challenges of VEGF & Immunotherapy Combinations Resistance patterns in patients disease…
Robert Uzzo, MD Fox Chase Center, explains how Value is a Function of Outcomes and Cost Optimal care is not…
Walter M. Stadler, MD University of Chicago, discusses Biomarker Data From Phase II Randomized Trial Study of Atezolizumab With or…
Brian M. Shuch, MD Yale School of Medicine, discusses the Difference Between Type 1 & 2 PRCC Although look similar…
Maxine Sun, MD Dana-Farber Cancer Institute, discusses The Use of Secondary Data Analysis Opportunity to produce high-impact research at Kidney…
Michael B. Atkins, MD Deputy Director Professor, Oncology & Medicine Georgetown Lombardi Comprehensive Cancer Center answers if there is Any…
Andrew Chi, MD, PhD at NYU Langone Medical Center Explains how Gliomas in Mid-Line Locations are Distinct in Both Genetic…
Michael B. Atkins, MD Deputy Director Professor, Oncology & Medicine Georgetown Lombardi Comprehensive Cancer Center answers how Data will not…
Michael B. Atkins, MD Deputy Director Professor, Oncology & Medicine Georgetown Lombardi Comprehensive Cancer Center answers What happens to patients…
Michael B. Atkins, MD Deputy Director Professor, Oncology & Medicine Georgetown Lombardi Comprehensive Cancer Center answers if doseage of axitnib…
Michael B. Atkins, MD Deputy Director Professor, Oncology & Medicine Georgetown Lombardi Comprehensive Cancer Center answers How do you indentify…
Pharmacists play a valuable role in oncology practice. Here, R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, from the Winship Cancer…
R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, from the Winship Cancer Institute, Atlanta, GA, gives a pharmacists perspective on the…
R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, from the Winship Cancer Institute, Atlanta, GA, discusses the importance of biomarkers in…
Here, the 2017/18 President of the Hematology/Oncology Pharmacy Association (HOPA), Susannah Koontz Webb, PharmD, BCOP, FHOPA, provides an insight into…
Year after year, the number of healthcare professionals that join the Hematology/Oncology Pharmacy Association (HOPA) continues to increase. Speaking from…
What can be expected from the Hematology/Oncology Pharmacy Association (HOPA) in 2018/19? Here, Susannah Koontz Webb, PharmD, BCOP, FHOPA, 2017/18…
It was a very productive year for the 2017/18 governance of the Hematology/Oncology Pharmacy Association (HOPA). Here, Susannah Koontz Webb,…
This year the Hematology/Oncology Pharmacy Association (HOPA) held its 14th Annual Conference in Denver, CO, with a record-breaking number of…